文献速递血栓与止血

基线血小板减少对急性静脉血栓栓塞症患者早期结局的影响

Impact of Baseline Thrombocytopenia on Early Outcomes in Patients With Acute Venous Thromboembolism.
PubMed 文献 · Am J Hematol · 2025-01-10

基于RIETE注册研究2003年3月至2022年11月90 418例急性静脉血栓栓塞症(VTE)患者,按基线血小板计数分为重度(<50 000/μL,n=303)、中度(50 000-99 999/μL,n=1882)和正常组。在52 703例肺栓塞(PE)患者中,15天PE致死率重度组5.8%、中度组4.5%、正常组1.1%;重度血小板减少者致命性PE风险约增五倍(调整HR 4.89;95%CI 2.55-9.39)。

要点

  • PE患者15天PE致死率:重度血小板减少5.8%,中度4.5%,正常1.1%。
  • 重度血小板减少者致命性PE风险约增五倍(调整HR 4.89;95%CI 2.55-9.39)。
  • 中重度血小板减少均与15天内大出血和复发性VTE风险增加相关。

核心结论

  • 急性VTE患者基线血小板减少与PE所致早期死亡风险增加相关,该发现由初始表现为PE的亚组驱动。

研究设计与样本

  • 使用RIETE注册研究数据,纳入2003年3月至2022年11月90 418例VTE患者。
  • 血小板减少分为重度(<50 000/μL,n=303)和中度(50 000-99 999/μL,n=1882)。
  • 主要结局为诊断后15天内致命性PE,次要结局包括大出血和复发性VTE,采用多变量调整模型分析。

主要发现

  • 52 703例PE患者中,15天PE致死率重度血小板减少组5.8%、中度组4.5%、正常血小板组1.1%。
  • 37 715例孤立性下肢深静脉血栓(DVT)患者中,致命性PE累积发生率重度组0、中度组0.2%、正常组0.05%。
  • 多变量分析显示重度血小板减少者致命性PE风险约增五倍(调整HR 4.89;95%CI 2.55-9.39),重度与中度血小板减少之间无显著差异。
  • 中度或重度血小板减少均与15天内大出血和复发性VTE风险增加相关。
  • 初始表现为PE较孤立性DVT显著恶化预后。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Managing acute venous thromboembolism (VTE) in patients with thrombocytopenia is challenging. We used data from the RIETE registry to investigate the impact of baseline thrombocytopenia on early VTE-related outcomes, depending on the initial presentation as pulmonary embolism (PE) or isolated lower-limb deep vein thrombosis (DVT). From March 2003 to November 2022, 90 418 patients with VTE were included. Thrombocytopenia was categorized as severe (< 50 000/μL, n = 303) or moderate (50 000-99 999/μL, n = 1882). The primary outcome, fatal PE within 15 days after diagnosis, and secondary outcomes, including major bleeding and recurrent VTE, were analyzed using multivariable-adjusted models. Among 52 703 patients with PE, the 15-day case-fatality rates from PE were 5.8% for severe thrombocytopenia, 4.5% for moderate thrombocytopenia, and 1.1% for normal platelet counts. In 37 715 patients with isolated DVT, the cumulative incidence of fatal PE were 0, 0.2%, and 0.05%, respectively. Multivariable analysis revealed a five-fold increase in the risk for fatal PE in severe thrombocytopenia (adjusted HR: 4.89; 95%CI: 2.55-9.39) without significant differences between severe and moderate thrombocytopenia. Thrombocytopenia, either moderate or severe, was also associated with increased risk for both, major bleeding and recurrent VTE at 15 days. Initial presentation with PE substantially worsened prognosis compared to isolated DVT. In conclusion, in patients with acute VTE, thrombocytopenia at baseline was associated with increased risk of early death from PE, a finding that was driven by the subgroup whose initial presentation was PE.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Lecumberri R, Ruiz-Artacho P, Trujillo-Santos J, et al. Impact of Baseline Thrombocytopenia on Early Outcomes in Patients With Acute Venous Thromboembolism. Am J Hematol. 2025. PMID: 39791523. doi:10.1002/ajh.27579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。